Inventor · disambiguated record
Zuojun Guo
Also filed as: GUO ZUOJUN
8 granted patents·7 pending applications·26 citations·filing 2017–2024
81Inventor score
Top patents by PatentIndex Score
15 records- 0188US10428067B2Compounds and methods for kinase modulationPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·8 cites·18 claims
- 0287US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 0385US10508085B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 17, 2019·6 cites·37 claims
- 0483US11807626B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2021·Granted Nov 7, 2023·1 cites·40 claims
- 0580US11149011B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2019·Granted Oct 19, 2021·2 cites·23 claims
- 0677US2024174659A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2023·Application pending·0 cites
- 0773US12202818B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2023·Granted Jan 21, 2025·0 cites·31 claims
- 0872US11446287B2Compounds and methods for EP300 or CBP modulation and indications thereforOPNA IMMUNO ONCOLOGY SA·Filed 2020·Granted Sep 20, 2022·1 cites·37 claims
- 0967US2025066356A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1064US2025129028A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2024·Application pending·0 cites
- 1163US2025270209A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1261US2025346593A1Imidazo(1,2-1)pyridine derivatives as ripk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1355US2023081426A1Compounds and methods for kras modulation and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 1453US2021315869A1Compounds and methods for csk modulation and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 1550US12509444B2Compounds and methods for CD73 modulation and indications thereforPLEXXIKON INC·Filed 2020·Granted Dec 30, 2025·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Zuojun Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →